The 4th World Congress on Controversies in Neurology (CONy) A Comprehensive Congress Fully Devoted to Clinical Debates and Controversial Issues in a Wide Spectrum of Neurological Conditions
October 28, 2010 - October 31, 2010
| Palau de Congressos de Catalunya
-
Since its launch in 2007, CONy has become established as a unique meeting where physicians can meet with outstanding experts in all neurology fields, and be updated on the most pressing clinical questions of the day.
-
CONy is a true educational experience that provides the audience insight into major changes in the rapidly evolving field of neurology and clinical neuroscience.
-
The program at CONy Congresses is designed to provide an effective forum for discussing and debating unresolved issues by allowing ample time for speakers/audience discussion.
-
CONy is the only Congress of its kind that focuses mainly on controversial issues in form of debates.
Presentations
DEBATE: Neuro-epistemology: Randomized controlled trials are the gold standard in neurorehabilitation - NO Plenary Session I
October 28, 2010 15:30
COMMENTARY: Neuro-epistemology: Randomized controlled trials are the gold standard in neurorehabilitation Plenary Session I
October 28, 2010 15:30
Open Access is the Future of Science DEBATE: Free access journals are important and useful
October 28, 2010 17:00
The Case Against Open Access Journals DEBATE: Free access journals are important and useful
October 28, 2010 17:30
DEBATE: Is Alzheimer's disease a homogeneous nosologic entity? YES Plenary Session II
October 28, 2010 18:00
DEBATE: Is Alzheimer's disease a homogeneous nosologic entity? NO Plenary Session II
October 28, 2010 18:30
DEBATE: Should hormonal therapy be used to treat epilepsy? YES! SEE also CON POSITION and COMMENTARY Epilepsy: Less Conventional Treatments
October 29, 2010 08:00
DEBATE: Hormonal Therapy should not be used to treat Epilepsy | SEE also PRO POSITION AND COMMENTARY Epilepsy: Less Conventional Treatments
October 29, 2010 09:00
COMMENTARY: Should hormonal therapy be used to treat epilepsy? SEE also PRO and CON POSITION Epilepsy: Less Conventional Treatments
October 29, 2010 09:30
DEBATE: Should recently approved antiepileptic drugs be used early in the treatment of epilepsy? The answer is YES. SEE also CON POSITION and COMMENTARY Epilepsy: Less Conventional Treatments
October 29, 2010 10:00
DEBATE: Should recently approved antiepileptic drugs be used early in the treatment of epilepsy? The answer is NO. SEE also PRO POSITION and COMMENTARY Epilepsy: Less Conventional Treatments
October 29, 2010 11:00
COMMENTARY: Should recently approved antiepileptic drugs be used early in the treatment of epilepsy? SEE also PRO and CON POSITION Should recently approved antiepileptic drugs be used early in the treatment of epilepsy?
October 29, 2010 12:00
DEBATE: Should patients with epilepsy who are depressed be routinely treated with antidepressant medication (ADM) or vagus nerve stimulation (VNS)? YES for VNS. SEE also ADM POSITION and COMMENTARY Epilepsy: Psychological Aspects
October 29, 2010 13:00
DEBATE: Should patients with epilepsy who are depressed be routinely treated with antidepressant medication or vagus nerve stimulation (VNS)? YES for ANTIDEPRESSANTS. SEE also VNS POSITION and COMMENTARY Epilepsy: Psychological Aspects
October 29, 2010 14:00
COMMENTARY: Should patients with epilepsy who are depressed be routinely treated with antidepressant medication (ADM) or vagus nerve stimulation (VNS)? SEE also ADM and VNS POSITION Epilepsy: Psychological Aspects
October 29, 2010 15:00
PREGABALIN New Players in Epilepsy
October 29, 2010 18:00
DEBATE: Does chronic venous insufficiency play a role in MS pathogenesis? YES SEE also CON POSITION and COMMENTARY Etiology and Pathogenesis of MS
October 30, 2010 11:00
DEBATE: Does chronic venous insufficiency play a role in MS pathogenesis? NO SEE also PRO POSITION and COMMENTARY Etiology and Pathogenesis of MS
October 30, 2010 11:30
COMMENTARY: Does chronic venous insufficiency play a role in MS pathogenesis? SEE also PRO and CON POSITION Etiology and Pathogenesis of MS
October 30, 2010 12:10
DEBATE: Are infections key environmental factors in MS? CON View SEE also PRO POSITION and COMMENTARY Etiology and Pathogenesis of MS
October 30, 2010 14:00
COMMENTARY: Are infections key environmental factors in MS? SEE also PRO and CON POSITION Etiology and Pathogenesis of MS
October 30, 2010 14:20
DEBATE: Is botulinum toxin type-A an effective and safe treatment for chronic migraine? YES SEE also CON View and COMMENTARY Headache: What causes post traumatic headache - Will CRGP antagonists be effective?
October 30, 2010 14:30
DEBATE: Is botulinum toxin type-A an effective and safe treatment for chronic migraine? NO SEE also PRO View and COMMENTARY Headache: What causes post traumatic headache - Will CRGP antagonists be effective?
October 30, 2010 14:40
COMMENTARY: Is botulinum toxin type-A an effective and safe treatment for chronic migraine? SEE also PRO and CON View Headache: What causes post traumatic headache - Will CRGP antagonists be effective?
October 30, 2010 14:50
DEBATE: Will the first marketed CGRP antagonist be an important addition to the migraine treatment armamentarium? YES SEE also CON View and COMMENTARY Headache: What causes post traumatic headache - Will CRGP antagonists be effective?
October 30, 2010 15:00
DEBATE: Will the first marketed CGRP antagonist be an important addition to the migraine treatment armamentarium? YES SEE also PRO View and COMMENTARY Headache: What causes post traumatic headache - Will CRGP antagonists be effective?
October 30, 2010 15:20
COMMENTARY: Will the first marketed CGRP antagonist be an important addition to the migraine treatment armamentarium? SEE also PRO and CON View Headache: What causes post traumatic headache - Will CRGP antagonists be effective?
October 30, 2010 15:40
DEBATE: Should all MS patients be treated with statins? YES SEE also CON View and COMMENTARY New Players in MS
October 30, 2010 16:00
DEBATE: Should all MS patients be treated with statins? NO SEE also PRO View and COMMENTARY New Players in MS
October 30, 2010 16:15
DIMETHYL FUMARATE New Players in MS
October 30, 2010 17:00
BONE MARROW STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS New Players in MS
October 30, 2010 18:15
TERIFLUNOMIDE New Players in MS
October 30, 2010 18:30
LAQUINIMOD: A NEW ORAL IMMUNOMODULATOR FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS New Players in MS
October 30, 2010 19:00
UPDATE ON CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING–REMITTING MULTIPLE SCLEROSIS New Players in MS
October 30, 2010 19:30
THE PLACE OF SURROGATE ENDPOINTS IN THE DEVELOPMENT NEW NEUROLOGICAL MEDICINES Biomarkers in Diagnositcs of Neurological Disorders
October 31, 2010 09:00
Infos
| Date | October 28, 2010 - October 31, 2010 |
|---|---|
| Program-Link: | http://comtecmed.com/cony/2010/scientific_prog.aspx |
| Website: | http://comtecmed.com/cony/2010/ |
| Location: | Palau de Congressos de Catalunya; |
| Organizer: | ComtecMed; |
| Category: | Medicine; |
Latest Presentations
Please activate JavaScript to see this video.
Videos are not working? If the videos are not working on your computer, make sure you have javascript enabled in your browser.
Trending Content Box
The 10 MOST VISITED WEBCASTS in April, 2013
- Should recently approved antiepileptic drugs be used early in the treament of epilepsy? the answer is no. By Prof. E. Beghi
- Dimethyl Fumarate by Prof. Jacek Losy
- Complete Mesocolic Excision: a way to standardize Colon Cancer Surgery by Prof. Werner Hohenberger
- Agents targeting the mTOR-PI3K-Akt pathway by Prof. J. Tabernero
- Prostate specific membrane antigen antibody drug conjugate PSMA ADC): a phase 1 trial in castration-resistant metastatic prostate cancer by Prof. D. Petrylak
- Bone marrow stem cell transplantation in mulitple sclerosis by Prof. D. Karussis
- Secretomics of endometrial fluid for non-invasive assessment of endometrial receptivity by Prof. Nick Macklon
- The global epidemiology of syphilis and the challenges and opportunities to address maternal and congenital syphilis by Prof. F. Ndow
- Adalimumab for induction of clinical remission in moderately to severe active ulceratice colitis by Prof. W. Reinisch
- Current management of AIN3 and cancer by Prof. S. Goldstone
Latest Congresses
April 07, 2013
February 24, 2013
March 15, 2012
November 17, 2011
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our Terms of use. Warning: Some websites may contain content of an adult nature. These pages are designed for ADULTS only.